ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1297

Factors Associated with Employment and Work Disability in Patients with SLE: A Nested Case-control Study

Connor Maddock1, Behdin Nowrouzi-Kia2, Jiandong Su3 and Zahi Touma4, 1University College Dublin, Dublin, Ireland, 2University of Toronto, Toronto, ON, Canada, 3University Health Network, Toronto, ON, Canada, 4University of Toronto, Mississauga, ON, Canada

Meeting: ACR Convergence 2021

Keywords: Employment, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III: Outcomes (1257–1303)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organ systems and can vary in its manifestations between individuals. SLE can range in severity, resulting in some patients being unable to continue working while others can remain employed.

The purpose of this study is to analyze and compare factors including SLE disease activity between work disabled and employed patients with SLE to elucidate variables associated with unemployment.

Methods: This is a cross-sectional study focused on the status of last employment reported in the data on 1110 adult SLE patients followed at a single centre where 746 patients were categorized as “Employed” and 364 as “Unemployed” (work disability or Sick Leave). In the employed group, 478 patients were matched to 297 patients in the unemployed group by 2:1 matching. Patients were matched on gender, inception status (whether patient was first seen at clinic within 12 months of SLE diagnosis), disease duration at last visit (+/- 3 years), ethnicity (Caucasian or non-Caucasian) and highest education level obtained. Associations between variables and employment status were assessed using univariate and multivariate conditional logistic regressions in a nested case-control study. Greedy matching algorithm was used to assemble the cases and controls. Patients’ characteristics were compared by paired t-test and McNemar’s test in matched cohorts, and a conditional logistic regression was performed to examine patients’ demographics, last five years’ disease activity, organ damage, disease burdens and treatment to the last employment status. Step-down variable selection method was adopted in the multivariable model building with Akaike Information Criterion (AIC) used as the model fitting statistics.

Results: The demographics of 775 patients were represented in Table 1. Patients in the unemployed group showed significantly greater disease activity (higher adjusted mean SLEDAI-2K and SLEDAI-K Glucocorticoid index (SLEDAI-2KG) in the past five years and greater damage by SDI). Patients were also found to have a significantly higher prevalence of myocardial infarction, stroke, fibromyalgia, hypertension, and higher daily and cumulative glucocorticoid use. In the multivariable analysis (Table 2), age at SLE diagnosis (OR, 95% CI: 1.04,1.02-1.06), adjusted mean SLEDAI-2KG in past five years (OR, 95% CI: 1.07, 1.03-1.12), SDI (OR, 95% CI: 1.59, 1.40-1.80) and prevalence of fibromyalgia (OR, 95% CI: 3.84, 2.52, 5.86) were associated with the increased risk of unemployment. We conducted additional modeling where adjusted mean SLEDAI-2KG was substituted by adjusted mean SLEDAI-2K and cumulative glucocorticoid dose in the past five years, and the results were similar to the previous model.

Conclusion: High disease activity, damage and use of glucocorticoids were associated with an increased likelihood of patients being unemployed. Similarly, fibromyalgia was strongly associated with a patient being unemployed. Employment status may be improved by better control of SLE disease activity and management of fibromyalgia and other risk factors.


Disclosures: C. Maddock, None; B. Nowrouzi-Kia, None; J. Su, None; Z. Touma, AbbVie Inc, 2, UCB Biopharma SRL, 2, Sarkana Pharma Inc., 1, 4, Janssen Inc., 2, GlaxoSmithKline Inc., 6.

To cite this abstract in AMA style:

Maddock C, Nowrouzi-Kia B, Su J, Touma Z. Factors Associated with Employment and Work Disability in Patients with SLE: A Nested Case-control Study [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/factors-associated-with-employment-and-work-disability-in-patients-with-sle-a-nested-case-control-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-associated-with-employment-and-work-disability-in-patients-with-sle-a-nested-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology